🇺🇸 FDA
Patent

US 12331110

Monoclonal antibodies against endotrophin and the use thereof

granted A61KA61K2039/505A61K39/3955

Quick answer

US patent 12331110 (Monoclonal antibodies against endotrophin and the use thereof) held by The Board of Regents of the University of Texas System expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61K39/3955, A61P, A61P35/00